CNBC
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
Related stories
Rio Times
BusinessAug 6, 2026 · 1 min
Rand Near Its Strongest in a Month as Brent Slips Below US$80
Rio Times
MarketWatch
BusinessAug 6, 2026 · 1 min
Honeywell Aerospace lands in Wall Street’s ‘penalty box’ after gloomy guidance triggers 21% stock selloff
MarketWatch
The New York Times
BusinessAug 6, 2026 · 1 min
Amid Cyclospora Outbreak, Demand for Locally Grown Lettuce Surges
The New York Times
AllAfrica
BusinessAug 6, 2026 · 1 min
Zimbabwe: Air Zimbabwe Restores Harare-London Flight Schedule As Fares Increase
AllAfrica